These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2554856)

  • 1. Evaluation of continuous cell lines in antiviral studies with murine cytomegalovirus.
    Smee DF; Colletti A; Alaghamandan HA; Allen LB
    Arch Virol; 1989; 107(3-4):253-60. PubMed ID: 2554856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
    Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER
    Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human cytomegalovirus replication in a human retinal epithelial cell model by antisense oligonucleotides.
    Detrick B; Nagineni CN; Grillone LR; Anderson KP; Henry SP; Hooks JJ
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):163-9. PubMed ID: 11133862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in murine cytomegalovirus replication in fibroblasts from different mouse strains in vitro: correlation with in vivo resistance.
    Harnett GB; Shellam GR
    J Gen Virol; 1982 Sep; 62 (Pt 1)():39-47. PubMed ID: 6290595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The folate antagonist, methotrexate, is a potent inhibitor of murine and human cytomegalovirus in vitro.
    Shanley JD; Debs RJ
    Antiviral Res; 1989 Mar; 11(2):99-106. PubMed ID: 2543289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth of murine cytomegalovirus in various cell lines.
    Kim KS; Carp RI
    J Virol; 1971 Jun; 7(6):720-5. PubMed ID: 4327583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
    Neyts J; De Clercq E
    Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection of mouse ectoplacental cone cells with murine cytomegalovirus.
    Baskar JF; Huang ES
    J Gen Virol; 1981 Jun; 54(Pt 2):415-20. PubMed ID: 6270259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A microtiter virus yield reduction assay for the evaluation of antiviral compounds against human cytomegalovirus and herpes simplex virus.
    Prichard MN; Turk SR; Coleman LA; Engelhardt SL; Shipman C; Drach JC
    J Virol Methods; 1990 Apr; 28(1):101-6. PubMed ID: 2161417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of human cytomegalovirus replication by naphthalenedisulfonic acid derivatives.
    Baba M; Konno K; Shigeta S; Wickramasinghe A; Mohan P
    Antiviral Res; 1993 Mar; 20(3):223-33. PubMed ID: 8385895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid phase ELISA for determination of the virus dose dependent sensitivity of human cytomegalovirus to antiviral drugs in vitro.
    Ståhle EL; Schloss L; Sundqvist VA; Brytting M; Hökeberg I; Cox S; Wahren B; Linde A
    Antiviral Res; 1998 Dec; 40(1-2):105-12. PubMed ID: 9864051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of acycloguanosine and trifluorothymidine as inhibitors of cytomegalovirus infection in vitro.
    Lang DJ; Cheung KS
    Am J Med; 1982 Jul; 73(1A):49-53. PubMed ID: 6285732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propagation and titration of murine cytomegalovirus in a continuous bone marrow-derived stromal cell line (M2-10B4).
    Lutarewych MA; Quirk MR; Kringstad BA; Li W; Verfaillie CM; Jordan MC
    J Virol Methods; 1997 Nov; 68(2):193-8. PubMed ID: 9389409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of clinical isolates of human cytomegalovirus and varicella zoster virus by PNU-183792, a 4-oxo-dihydroquinoline.
    Knechtel ML; Huang A; Vaillancourt VA; Brideau RJ
    J Med Virol; 2002 Oct; 68(2):234-6. PubMed ID: 12210413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of murine cytomegalovirus disease does not prevent latent virus infection.
    Katzenstein DA; Crane RT; Jordan MC
    J Lab Clin Med; 1986 Aug; 108(2):155-60. PubMed ID: 3016127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication of herpesviruses in human cells transformed by cytomegalovirus.
    Figueroa ME; Geder L; Rapp F
    J Gen Virol; 1978 Aug; 40(2):391-8. PubMed ID: 211187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between human cytomegalovirus pUL97 and murine cytomegalovirus (MCMV) pM97 expressed by MCMV and vaccinia virus: pM97 does not confer ganciclovir sensitivity.
    Wagner M; Michel D; Schaarschmidt P; Vaida B; Jonjic S; Messerle M; Mertens T; Koszinowski U
    J Virol; 2000 Nov; 74(22):10729-36. PubMed ID: 11044117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of antiviral activity of different origin compounds by flow cytometry.
    Siennicka J; Trzcińska A; Kańtoch M
    Acta Microbiol Pol; 2002; 51(1):79-83. PubMed ID: 12184452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid assay for determination of antiviral activity against human cytomegalovirus.
    Hippenmeyer PJ; Dilworth VM
    Antiviral Res; 1996 Aug; 32(1):35-42. PubMed ID: 8863994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cell source, mouse strain, and immunosuppressive treatment on production of virulent and attenuated murine cytomegalovirus.
    Selgrade MK; Nedrud JG; Collier AM; Gardner DE
    Infect Immun; 1981 Sep; 33(3):840-7. PubMed ID: 6270000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.